A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia
Clinical trial NCT04943497 · COMPLETED
Trial details
- NCT number
- NCT04943497
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-07-27
- Primary completion
- 2025-07-28
- Enrollment
- 2390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.